🇺🇸 Pravafen in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 10

Most-reported reactions

1. Condition Aggravated — 1 report (10%)
2. Cough — 1 report (10%)
3. Dyspnoea — 1 report (10%)
4. Epidermolysis — 1 report (10%)
5. Hepatitis Acute — 1 report (10%)
6. Herpes Zoster — 1 report (10%)
7. Hot Flush — 1 report (10%)
8. Influenza Like Illness — 1 report (10%)
9. Myocardial Infarction — 1 report (10%)
10. Rash — 1 report (10%)

Source database →

Frequently asked questions

Is Pravafen approved in United States?

Pravafen does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Pravafen in United States?

Shionogi is the originator. The local marketing authorisation holder may differ — check the official source linked above.